Clinical Trials Directory

Trials / Completed

CompletedNCT02480504

Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

A randomized clinical trial comparing the effect on weight reduction and cardiometabolic risk factors of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects.

Detailed description

Background: The optimal diet for treating obesity and cardiovascular disease (CVD) risk is still not clarified. Could a five plus two diet, a form of intermittent energy restriction lead to good adherence, similar weight loss and reduction in CVD risk factors as a isocaloric continuous energy restrictions in obese subjects. Methods: The study is a randomized controlled clinical trial in 120 men and women between 21 to 70 years with BMI (BMI 30-45 kg/m2), stable weight within ±3 kg last 3 months and 1 additional metabolic syndrome risk component. Dietary intervention: Randomization will be to one of two diet groups. Participants in the intervention group will follow av 5:2 diet and participants in the control group will follow an isocaloric continuous energy restriction. Primary research question: Compare the effect on weight reduction of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects? Secondary research questions Compare the effect of intermittent energy restriction and an isocaloric continuous energy restriction on cardiometabolic risk factors and tolerability and safety in obese subjects. The project consist of to randomized controlled clinical trials.

Conditions

Interventions

TypeNameDescription
OTHERdietary intervention intermittent energy restrictionRandomized clinical trial
OTHERcontinuous energy restriction

Timeline

Start date
2015-09-01
Primary completion
2017-04-25
Completion
2017-04-25
First posted
2015-06-24
Last updated
2017-07-17

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02480504. Inclusion in this directory is not an endorsement.